Receive The Newest Study Notifications

HempMy Pet™ Announces a CSU Clinical Trials Study using their Hemp-derived CBD Oil to Manage Pain in Osteoarthritic Dogs, in Collaboration with Colorado State University College of Veterinary Medicine and Biomedical Sciences, and Downing Center for Pain Management...

New Clinical Trial Adds to Growing Number of Studies Supporting Use of Signatera as a Potential Surrogate Endpoint Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will partner with AMAL Therapeutics on a clinical trial focused on stage IV...

dysfunction (ED). With this feedback, CURE anticipates submitting its IND application in preparation for multiple clinical trials starting in Q3 of 2019. “Receiving the FDA’s guidance is a key step toward executing our clinical development program,” said Rob Davidson,...

- Investigational compound fezolinetant reduced frequency and severity of vasomotor symptoms in postmenopausal women - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced results from a Phase 2b dose-finding study of...

SENS-111 phase 2 AUV trial: major progress with 75% of patients enrolled in the clinical trial assessing the efficacy of SENS-111 on vertigo intensity SENS-111 phase 2a trial: the phase 2a trial has achieved its tolerance primary end point; SENS-111 affects neither...

Researchers to lead stroke study in children under 2 Strokes are devastating events often associated with people over 65. But large numbers of infants have strokes, too. Now, in the nation's first multicenter pediatric stroke recovery trial, researchers and clinicians...

At present, medical practitioners have few options when they are presented with a patient with leukemia. The Leukemia & Lymphoma Society's website points out that : "It's important that your doctor is experienced in treating patients with acute leukemia or has...

dysfunction (ED). With this feedback, CURE anticipates submitting its IND application in preparation for multiple clinical trials starting in Q3 of 2019. “Receiving the FDA’s guidance is a key step toward executing our clinical development program,” said Rob Davidson,...

Trialbee, a world leading technology provider in patient matching and engagement, and Linical Accelovance Group, a market-leading, midsized, global contract research organization (CRO), announce they will join forces to drive the next generation of digitally powered...

Global’s doctors participate in research exploring the safety and improvement of protocols using adipose-derived stem cells. Global Stem Cells Group, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering...

Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the first patient has been treated...

On January 23, 2019, the EU Data Protection Board (“EDPB” - the gathering of all European Union (EU) data protection authorities) adopted opinion no. 3/2019 (the “Opinion”) on the interplay between the Clinical Trials Regulation no. 536/2014 “CTR”) and the General...

One patient to proceed to potentially curative bone marrow transplant; no cardiotoxicity observed Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly...

- Primary endpoint of ocular itch score area under the curve achieved for both tested reproxalap concentrations - Key secondary endpoint of clinically relevant two-point ocular itch score improvement achieved for both tested reproxalap concentrations - Company closed...

-- New data suggests that 525 mg dose and 700 mg dose responders’ rates are approximately 90% for those HIV patients who pass first 10 weeks of monotherapy without virologic failure -- CytoDyn has engaged top CCR5 expert, Bruce Patterson M.D., former Medical Director...

- Results establish favorable safety profile and show the potential for efficacy with once-weekly dosing of a next generation GLP-2 analog - In head-to-head rat studies, apraglutide displayed a longer half-life and induced greater intestinotrophic effects when...

Veeda Clinical Research Pvt. Ltd., a leading independent CRO, is pleased to announce that our clinical (Shivalik, Ahmedabad) and Bioanalytical facilities (Insignia, Ahmedabad) have successfully completed the third inspection by NPRA (Malaysian Regulatory Agency). This...

Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that it received Clinical Trial Application and Ethics Committee approvals for the company's Phase 2 study of imlifidase in...

Murrieta Genomics, the genomic sequencing business incubator, has agreed with Alliance Research Centers, a comprehensive clinical research site management organization, to offer genomic sequencing services to trial sponsors and participants as an additional service....

Shortfall on Primary Endpoint Shifts Focus for Emricasan to Ongoing NASH Cirrhosis Trials Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced top-line results from the company’s Phase 2b ENCORE-NF clinical trial in patients with biopsy-confirmed nonalcoholic...